Nolan Townsend, MBA

Regional President, North America Rare Disease business, Pfizer

Nolan Townsend is Regional President, North America for Pfizer’s Rare Disease business. In this role, Nolan is responsible for Pfizer’s Rare Disease P&L and commercial organization across the United States and Canada.

Nolan joined the North America Rare Disease business from a prior role as Regional President, International Developed Markets for Pfizer Rare Disease based in the United Kingdom and responsible for the Rare Disease business across Europe and parts of Asia. He has over a decade of experience with Pfizer, first joining the company in the Corporate Finance Division and in roles of increasing responsibility in Corporate Finance, Corporate Strategy, Business Operations, Marketing, and General Management in Pfizer’s New York headquarters, Asia, Eastern Europe and the Africa/Middle East region.

In the context of earlier Country Management positions, Nolan undertook industry wide leadership roles where he was elected to the Board of Directors of the Association of International Pharmaceutical Manufacturers of Romania (ARPIM) in 2014, the Board of Directors of the American Chamber of Commerce in Romania (AMCHAM) in 2015, as Chairman of the Association of Pharmaceutical Research and Development in Ukraine (APRaD) in 2013, and as Chairman of the Healthcare Committee of the American Chamber of Commerce in Ukraine in 2012.

Prior to Pfizer, Nolan was an investment banker with Lehman Brothers in New York focusing on M&A and financing transactions for healthcare companies. He received his MBA from the Harvard

Meet the rest of the NASP board of directors and staff.